Unicharm (OTCMKTS:UNICY - Get Free Report) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 4,700 shares, anincreaseof487.5% from the June 30th total of 800 shares. Based on an average daily trading volume, of 1,146,100 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 1,146,100 shares, the days-to-cover ratio is currently 0.0 days.
Unicharm Stock Down 8.3%
UNICY traded down $0.30 during trading on Tuesday, reaching $3.30. The company had a trading volume of 342,014 shares, compared to its average volume of 577,119. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.31 and a quick ratio of 1.86. The business's fifty day moving average price is $3.69 and its 200 day moving average price is $3.95. Unicharm has a 12 month low of $3.06 and a 12 month high of $8.10. The company has a market cap of $11.57 billion, a P/E ratio of 16.50 and a beta of 0.22.
Unicharm (OTCMKTS:UNICY - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.03 earnings per share for the quarter. Equities analysts anticipate that Unicharm will post 0.17 EPS for the current year.
About Unicharm
(
Get Free Report)
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
See Also
Before you consider Unicharm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.
While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.